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Abstract 
Introduction: Dental Cone beam CT has encountered great success in diagnostics and 
treatment planning in dentistry. However, it makes use of ionizing radiation. Lots of 
concern on the effects of x-rays on vital organs of the head and neck region has been 
raised. Clarity on the amount of radiation received on these specific organs will be a 
contribution to a better use of the emergent technology. 
Aim: The aim of this study is to determine the potential dose of radiation received on 
the eye and thyroid and to quantify the amount of potential scatter on the gonads during 
CBCT examinations. 
Material and Methods: Calibrated Lithium- Fluoride thermoluminescent dosimeters 
were inserted inside an anthropomorphic phantom, on sites of the eye, thyroid and the 
gonads. After its submission to a CBCT examination, using the high and standard 
resolution for a similar scanning protocol, the dose of radiation received on each organ 
was calculated according to the ICRP guidelines. 
Results: An equivalent dose of 0.059 mGy was calculated for the eye. Compared to the 
threshold dose of 0.5 Gy fixed by the ICRP 2007, this can be considered as relatively 
low. The thyroid with an effective dose of 23.5 µSv represented 20% of  the full body 
effective dose existing in literature.  The gonads absorbed an effective dose of 0.05 
µSv, which was considered as negligible.                                                        
Conclusion: The doses calculated were considered as relatively low. However, dentists 
must be aware of risks of cumulative exposure. Therefore adherence to the ALARA 
principle and consideration of clinical indication for CBCT remain a priority.  
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CHAPTER I: INTRODUCTION 
 
I.1 Introduction  
Technology has undergone profound changes during the past century. New equipment 
is available in all sectors of life, from communications to dentistry. 
In the dental field, Cone Beam Computed Tomography (CBCT) is one of the most 
important technical innovations to this day1. This contemporary radiological imaging 
modality is specifically designed for use on the maxillo-facial skeleton. 2, 3, 4 
Prior to this new apparatus, oral and maxillofacial radiology mainly utilized two types of 
imaging modalities in order to visualize hard tissue lesions. On one hand, there were 
intra- oral surveys, panoramic radiographs and several extra oral views. Whether digital 
or analogue, they were considered as Conventional Radiography (CR)  
 On the other hand, there was Computed Tomography (CT), which provided a 
multiplanar accurate image of the exposed area. However, due to economic reasons, 
lack of expertise and great amount of exposure to ionizing radiations, CT was reserved 
for specialized imaging, depending on specific patient indications. This latter modali ty 
was able to produce three-dimensional projections which in certain cases proved useful 
in some aspects of dentistry. 
These two technologies were considered as the standards of care in Oral and Maxillo -
facial imaging.5 
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1.1.1 Definition 
When evaluating an emerging technology, the ideal approach is to compare it with the 
existing gold standard, and make sure that its diagnostic accuracy is better, or at least, 
as good as the one it can be expected to replace. 1, 5  
Dental CBCT, can therefore be defined as an imaging modality that provides high 
resolution cross-sectional images of an exposed area limited to the maxillo-facial 
complex, analogous to CT, and which offers the capacity of a 3D reconstruction of that 
same area. 5 
1.1.2 Advantages and limitations 
The first advantage of dental CBCT is that it overcomes the limitations of CR and 
produces an image that is accurate, undistorted and reproducible.4 Indeed, the amount 
of information gained from conventional or digitally captured plain radiographs was 
limited by the fact that the three-dimensional anatomy of the area being exposed is 
compressed into a two-dimensional image.                          
As a result of superimposition, two-dimensional radiographs reveal limited aspects of 
three-dimensional anatomy, requiring, in most cases, a combination of different 
conventional films taken in various planes.6Another benefit of CBCT is the production of 
a multi planar image similar to CT for a less amount of radiation. Studies comparing 
these two imaging techniques have shown that in terms of image quality, reproducibility 
and validity CBCT produced superior images to the helical CT, with less radiation 
exposure.5,7,8 It has been reported that the average effective radiation dose from CBCT 
varies from   36, 9 to 50, 3 µSv. This is considered a 98% reduction, when compared to 
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established CT systems.5, 9 For this reason, CBCT has been recommended as a dose-
sparing technique for oral and maxillo-facial imaging. 5, 10 Relative affordability, x-ray 
beam limitation with the possibility of different scan protocols and rapid scan time are 
other reasons to make use of this impressive invention.11 The superiority of dental 
CBCT compared to CT and CR is therefore well illustrated. 
 Unfortunately, like all excellent technologies, this machine has its limitations. One must 
bear in mind that the effective dose from CBCT is still considerably higher than that from 
CR.10, 13, 14Although better than CT from a radiation point of view, CBCT is just as much 
affected by radiographic artifacts related to the x-ray beam. This reflects as a distortion 
of images of metallic structures and the appearance of streaks and dark bands between 
two dense structures. Furthermore, patient movement during the scan can affect the 
sharpness of the final image.4, 11                                                      
 A third disadvantage is that it can only demonstrate limited contrast resolution, mainly 
due to relatively high scatter radiation during image acquisition. CBCT would not pose a 
problem were the objective of the inquiry to visualize hard tissue only. However, it is 
insufficient for soft tissue imaging.5 
Difficulty of interpretation may be considered a limitation.10 Yet, the major inconvenience 
of this emerging technology remains the use of ionizing radiation. Risks related to the 
radiation doses generated by CBCT have been noted.1 According to the 2009 ICRP 
reports, the risk of adult patient fatal malignancy related to CBCT is estimated to be 
between 1/100000 and 1/350000 individuals. For children, it can be twice as much.5 
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1.1.3 Effects of ionizing radiation 
Ionizing radiations, such as X rays, cause ionization of atoms, molecules, cells, tissues, 
organs and eventually the whole body. This depends on the amount of radiation 
received. 
The response of organs to ionizing radiations depends on the sensitivity of each tissue.  
It has been reported that reproductive cells as well as the intestinal mucosa have a high 
sensitivity to ionizing radiation. 
The salivary glands, the lens of the eye and the thyroid gland, on the other hand are 
slightly less sensitive. Muscle and nerve tissues have been classified as relatively 
insensitive.9 With regard to tissue responses to radiation exposure; two types of effects 
have been described. Effects that depend on a certain threshold dose of exposure are 
called non stochastic or deterministic effects, whereas the effects that are independent 
of a minimal dose of exposure are known as stochastic effects.15 
For the purpose of this study, our focus will be on the effects of ionizing radiations on 
specific organs in the maxillo-facial region, as well as on the gonads situated in the 
pelvic region. Indeed, although situated in the lower abdomen, the gonads may be 
involuntary victims of scatter radiation during patient exposure to CBCT. 
The lens of the eye contains a single layer of highly active dividing epithelial cells which 
are sensitive to ionizing radiation.  Some of these cells differentiate into mature lens 
fibre cells.  Lens transparency depends on the good condition of this layer. Ionizing 
radiation may lead to mutation or death of these sensitive cells and cause disruption of 
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this layer. This may cause clouding of the lens and therefore cause the impairment of 
vision known as cataract.16 The ICRP considers cataract as a non-stochastic effect of 
ionizing radiation. They recommend an equivalent dose limit of 20mSv in a year, 
averaged over a period of 5 years, with no single year exceeding 50mSv. The threshold 
lens dose for radiation induced cataract is now at 0.5 Gy.16,17                                                             
The thyroid has been classified as an organ with a relatively low sensitivity to ionizing 
radiation. This means that cell damage that may lead to cancer may occur at a minimal 
dose, particularly before the age of 12.15 Thyroid cancer is classified as a stochastic 
effect of radiation by the ICRP. 18 
Generative cells are highly sensitive to ionizing radiation and there is no threshold dose 
for cell injury. Exposure of the gonads may lead to damage of reproductive cells and 
induce cell death or mutation.  While cell death can lead to a reduction in the number of 
gonads, mutation can lead to affected kindred cells that may harbor cancer or 
malformations.19  
In dental and maxillo-facial diagnostic imaging, the amount of exposure seldom reaches 
the threshold doses for the eye. The chances of attainment of doses able to induce a 
chain of cellular reactions that may lead to cancer in organs such as thyroid or gonads 
are very low. However these doses are cumulative within a certain period of time. 
Therefore, there is a risk of cell damage if the patient is submitted to repeated 
exposures within a limited period. CBCT examinations are on the increase due to its 
popularity. As a consequence thereof, patients face a greater risk of cumulative doses 
of radiation. Dentists must therefore be aware of these consequences and take 
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necessary precautions in order to prevent future mutagenesis, carcinogenesis or 
teratogenesis.   
1.1.4 Method of calculation of effective dose of radiation 
Determination of the dose or quantity of the radiation exposure is regulated by a part of 
physics sciences called dosimetry. This science provides estimates of the biologic 
effects of radiation and therefore permits its proper therapeutic and diagnostic usage.22                                                                      
Dosimetry utilizes several concepts, but the most relevant to our study are absorbed 
dose, equivalent dose, effective dose, and the personal dose equivalent. 
Absorbed dose is expressed in Grays (Gy). It describes the energy absorbed from any 
type of ionizing radiation per unit mass of any type of matter.22 
Equivalent dose is more specific to the type of radiation concerned because it takes 
into consideration the Radiation Weighting Factor (W R) 
Equivalent dose (Hт) = Absorbed dose X Radiation weighting Factor  (1)          
Sieverts (Sv)             =            Gy          X       WR 
HT may be expressed in Sv.                                                                          
For the X-rays, the radiation weighting factor is 1. W R is provided by the ICRP. 
Effective dose takes into consideration the biologic risks in humans exposed to 
radiation. In other words it considers the absorbed dose of radiation, the type of 
radiation, sensitivity and carcinogenic potential of the irradiated tissue, even without a 
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threshold dose. It therefore takes into consideration the possibilities of stochastic effects 
of radiation which are expressed by the Tissue Weighting Factor (W T). (Table 1) 
Wт is provided and updated by the ICRP. The
 fraction of organ exposed (ƒ) is as well 
taken into consideration. It is expressed in percentage. 18, 21, 22   
         E= Hт x ƒ x Wт (2)  
Personal dose equivalent Hp(d) is an operational quantity defined by the International 
Commission on Radiation Units and measurements (ICRU) and the ICRP. It is 
recommended for monitoring low penetrating particles, such as β-particles as well as for 
assessment of doses of radiation on external surfaces. The personal dose equivalent 
utilized for the calculation of effective doses is Hp(10).The skin and the lens of the eye 
are considered as external surfaces. The ICRP 2007 recommends a personal 
equivalent dose of Hp (0.07) for the determination of an equivalent dose for these two 
organs.26The previous ICRP recommendation of Hp (3) for the lens of the eye was 
discontinued in 2007.26 The determination of Hp (0.07) requires a particular method of 
calibration of dosimeters using specific phantoms  according to the selected external 
surface.8,10,27 In the equation of calculation of equivalent dose, the factor absorbed dose 
is not a reading anymore, but a calculation using a specific conversion coefficient 
relative to the method of calibration.16,18,23,24 
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Table 1: Tissue weighting factors (ICRP 2007) 
18, 22 
Organ Tissue Weighting Factor(WT) 
Gonads 0.08 
Red Bone Marrow, Colon, Lungs, Stomach, Breast, Remainder 
tissues*  
0.12 
Bladder, Oesophagus, Liver, Thyroid   0.04 
Bone surface, Brain, Salivary glands, Skin 0.01 
*Remainder tissues:  
Adrenals, Extrathoracic (ET) region, Gall bladder, Heart, 
kidneys, Lymphatic nodes, Muscle, Oral mucosa, Pancreas, 
Prostate, Small intestine, Spleen, Thymus, Uterus/cervix 
0.12 
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1.2 Literature review 
 
 Several dosimetry studies on CBCT exist in literature and most of these studies rely on 
the use of TLDs. In this regard, the reliability of LiF (Lithium-Fluoride) chips has been 
proven. In 1987, Buch and Keddy conducted a study which demonstrated the reliability 
of LiF chips. These TLDs have the characteristic of exhibiting relatively null 
mechanically induced luminescence as well as the ability to store the information about 
the irradiation received. As a result, these TLDs are indicated for experiments which 
require displacements to sites remote from the measuring laboratory for purpose of 
exposure.25  
 Unfortunately, LiF dosimeters have two disadvantages. They present non-linear 
responses at high doses and are subject to background radiation at low doses.  
Although relevant, these disadvantages have been cited in studies carried out on LiF in 
the form of loose powder.25                                                                                                                                             
LiF dosimeters historically existed in the form of rods and discs, but their major 
shortcoming was that of orientation dependence. There was a significant difference in 
readings in small surfaces compared to larger surfaces, with identical exposures.25 The 
limitations of LiF in the form of loose powder were overcome by the use of LiF discs, 
that were submitted to a calibration of 1Gy of ionizing radiation from a standard source 
and submitted to the specific selection criteria of 5% below the mean dose calculated.25  
In 2006, Ludlow et al. published a dosimetry study on three different oral and maxillo-
facial CBCT devices. For this purpose, they utilized LiF TLD chips that were selected as 
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advised in previous literature.25The exposures were effectuated on a Radiation 
Analogue Dosimeter (RANDO®) phantom in which the TLDs were inserted.  This study 
determined the anatomical landmarks for insertion of TLDs and emphasized the use of 
effective dose as well as the influence of, kV, mA settings different FOVS in dosimetry 
studies.  Although it did not make use of the Galileos Comfort ® CBCT, and calculated 
average body effective doses, this study is often used as a reference for dosimetry, with 
organ dose measurement as a research methodology.26  
In 2008, Ludlow and Ivanovic compared the doses on CT with several CBCT devices, 
including the Galileos® Sirona with the scan protocol of 85kV, 42 mA on full FOV.                                                                                                                 
This article focused on the doses in the maxillo-facial area and introduced the, ICRP 
tissue weighting factors (2007) as well as different CBCT scan protocols. They 
calculated equivalent doses of radiation for specific organs in the maxillo-facial region. 
The thyroid absorbed an equivalent dose of 450µSv with the Galileos at maximum 
exposure. The equivalent dose for the eye was not mentioned. The effective doses 
calculated were average full body doses.10 
 In a 2012 publication, Pauwels et al. elaborated on the effective dose for dental CBCT 
scanners. They calculated the doses on several machines, including the Galileos 
Comfort® CBCT. Unfortunately, they used a CBCT scan protocol of full FOV, 85kV and 
28mA. They calculated equivalent organ doses and recorded a dose of 380µSv for the 
thyroid. The eye was not mentioned and the effective doses calculated were average 
full body doses. 27 
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During the same year, Thorsten et al. compared the dosimetry of the CBCT with a 
digital X-ray machine in orthodontic imaging. For this purpose, he used organ dose 
measurement methodology, based on Ludlow’s approach. The machines used for 
performing the exposures were i-CAT next generation® CBCT and an 
orthopantomograph OP100/OC 100®.  The existing scan protocols for i-CAT next 
generation® and the Galileos Comfort® are different. They calculated equivalent doses 
for the organs in the maxillo-facial area. The thyroid’s dose was of 167, 267, 150 and 
350µSv according to the different scan protocols. The eye was excluded. The effective 
doses calculated for the different machines were average full body doses.  They proved 
that the dose from CBCT was higher than the one from digital panoramic radiographs. 
Their conclusion was that, while information gained from a CBCT examination was 
benefic, it was the practitioner’s discretion to weigh between the risks encountered by 
the patient and the benefit from the examination. 20 
In 2013, surface skin doses were measured after exposure with four dental x-ray 
imaging systems. For this purpose, three CBCT units and one combined conventional 
panoramic-cephalometric unit were utilized. The latter unit was ProMax® pan/ceph x-ray 
machine, while the CBCTs were Kodak 950® (Kodak Dental Systems, Care stream 
Health, Rochester, NY, USA), i-CAT next generation® and Galileos Comfort®. The 
selected FOVs were the large and medium ones only. This selection was justified by the 
popularity of these FOVs in orthodontics for diagnostic and treatment planning. Several 
scan protocols were included in the study. Amongst others, the full FOV, 85 kV. 42mA. 
The dosimeters utilized for this purpose were optically stimulated luminescence (OSL) 
dot dosimeters (nanoDOTS® dosimeters, Landauer Corp. Glenwood IL) and the 
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phantom was a head anthropomorphic phantom RS110® (Radiology Supported 
Devices-RSD- Inc., Long beach, CA). The selected skin points for placement of the 
dosimeters were on the lens of the eyes, the parotid glands, the submandibular gland 
and the thyroid. After exposure of the phantom, according to the usual patient 
positioning protocol in a CBCT machine, the TLDs were read and the figures reported 
were converted into absorbed dose in mGys, using unit and scan specific calibration 
factors. With the protocol scan of 85kV, 42mA and full FOV, for the Galileos Comfort® 
CBCT the lens of the eye’s calculated absorbed dose was 0.94mGy.The highest dose 
observed for the lens of the eye was of almost 4mGy with a scanning protocol of 120kV, 
108mA and 20x18 FOV. The absorbed dose calculated at the skin surface on the 
thyroid was of 0.46mGy, for the full FOV scan protocol 85kV, 42 mA. They justified this 
negligible dose by considering the skin covering the anterior part of the thyroid gland as 
out of the primary x-ray beam.28    
In 2014, a study in Ontario calculated effective doses of different protocols using the 
Sirona Galileos Comfort CBCT®. They used the organ dose approach in their 
methodology, but the thermoluminescent chips were InLight®  nanoDot TM OSL 
dosimeters (Landauer, Glenwood, III) placed on Polymethyl methylacrylate (PMMA) 
templates. These dosimeters were positioned on a RANDO phantom with referral to 
Ludlow’s anatomic landmarks. Twelve scan protocols were used, including the Full FOV 
HR (VO1) and the Full FOV standard (VO2) at 85kV, 42mA. The calculated effective 
doses were maxillo-facial average dose.  The scatter was considered negligible. Our 
focus in this publication was on the calculated effective doses of protocol Full FOV HR 
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85kV, 42mA resulting in 142µSv compared to Protocol full FOV standard resolution 
85kV, 42mA resulting in 140µSv. 
This suggested that the changes in resolution settings had little or any impact on 
effective dose.22 
 Finally, the manufacturer provided average full body effective doses on the different 
settings, referred from a study by Ludlow JB on the dosimetry of the Galileos Dental® 
CBCT provided settings. (Table 2) It was reported that in smaller FOVs (maxillary or 
mandibular collimation) dose values could be reduced by approximately 15%.29 
Various reports on doses from CBCT have been published in the literature yet many of 
them refer to average full body doses or facial doses rather than to specific vital organs. 
Studies are still needed in order to determine radiation safety for specific organs in the 
maxillofacial region, as well as the effects of scatter radiation during CBCT 
examinations. The question still remains, however, whether or not the use of CBCT as a 
routine imaging modality for dental diagnosis induces overexposure to the patients.   
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1.3 Aim of the study 
WITS Dental School has recently acquired the Galileos Comfort CBCT scanner. The 
manufacturers refer to average full body doses rather than to specific vital organs.29 
Most of the studies refer to average effective doses.  It would appear that effective 
doses to specific regions of the face have been ignored. 
It is established that exposed dose is influenced by the parameters FOV, kVs and mAs 
settings.26, 28, 30 Yet, comparisons of amount of exposure at the different resolution 
settings, as well as the amount of scatter, particularly at the pelvic region, remain to be 
investigated.      
The specific aim of the current study is therefore to calculate the potential effective 
doses of radiation to specific vital organs in the head and neck region emanating from 
the CBCT scanner housed in the WITS Dental School at different resolution settings 
(VO1 and VO2). It also aims to investigate the amount of scatter radiation to the pelvic 
region for both scan protocols. The results of these observations are to be compared 
with the average effective doses described in the literature as well as background 
radiation.  
It is hoped by means of this study to contribute to the elaboration of conclusions 
relevant to the situation in South Africa. 
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1.4 Objectives 
Primary objectives 
The primary objectives of this study are: 
-To calculate the potential effective dose of radiation to the lens of the Right eye after 
exposure to the Galileos Comfort CBCT scanner on the setting VO1, 85kV, 42mA        --
-To calculate the potential effective dose of radiation to the lens of the Left eye after 
exposure to the Galileos Comfort CBCT scanner on the setting VO1, 85kV, 42 mA                                                                                                                          
-To calculate the potential effective dose of radiation to the lens of the Right eye after 
exposure to the Galileos Comfort CBCT scanner on the setting VO2, 85kV, 42mA 
-To calculate the potential effective dose of radiation to the lens of the Left eye after 
exposure to the Galileos Comfort CBCT scanner on the setting VO2, 85kV, 42 mA         
-To calculate the potential effective dose of radiation to the thyroid gland after exposure 
to the Galileos Comfort CBCT scanner on the setting VO1, 85kV, 42mA                          
-To calculate the potential effective dose of radiation to the thyroid after exposure to the 
Galileos Comfort CBCT scanner on the setting VO2, 85kV, 42mA                                     
-To calculate the extent of scatter radiation to the gonads during maxillofacial 
examinations using the Galileos Comfort CBCT scanner on the setting VO1, 85kV, 
42mA                                                                                                                                  
- To calculate the potential extent of scatter radiation to gonads during maxillofacial 
examinations using the Galileos Comfort CBCT scanner on the setting VO2, 85kV, 
42mA 
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Secondary objectives                
The secondary objectives of this study are: 
-To compare the calculated effective doses with the average effective doses as stated 
in the literature 
-To compare the calculated effective doses on the two different scan protocols 
-To determine whether or not there is a need for additional protection of the patient 
during such examinations                                                                                                   
-To compare the equivalent absorbed dose on the eye with the threshold dose at the 
eye fixed by the ICRP 2007. 
-To compare the calculated effective doses with the background radiation. 
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CHAPTER II: MATERIALS, METHODS AND RESULTS 
 
2.1 Introduction  
A systematic review of the different methodologies employed in dosimetry studies for 
CR, CT and CBCT has revealed that most of the studies encountered in literature have 
utilized the method of organ dose measurement.21                                                                                                                
This method relies on phantoms, implanted with dosimeters. 10, 14, 20, 21,26, 31, 32  
Other methods such as computer tomography dose index by volume (CTDIvol), Monte 
Carlo dose simulation programs, CT air-kerma length product (PKL, CT), Air kerma area 
product (PKA), entrance skin surface dose and energy imparted have as well been 
described.22 
However, our study will rely on the organ dose measurement method. The calculations 
of effective doses will be based on the absorbed dose measurements on the dosimeters 
inserted inside a phantom, the radiation weighting factors, the tissue weighting factors 
and the fraction of irradiated organ.                                                                                          
The phantom simulates human tissues with regard to tissue layers and radiation 
absorption factors. It is therefore called an anthropomorphic phantom. Such phantoms 
are fabricated with a natural human skeleton cast inside a material that has a radiologic 
density equivalent to that of soft tissue. It is virtually indestructible, capable of 
withstanding substantial impact and continuous handling without damage. These 
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phantoms are constructed in the form of detachable cross-sections with apertures 
created for placement of dosimeters in the region of interest. 33 
 The specific phantom to be used is the RANDO® (Radiation Analogue Dosimeter, The 
Phantom laboratory, Salem, NY)   
The selected organs were the lens of the L eye, the lens of the R eye, the thyroid 
gland and the gonads in the pelvic region. The first two organs were retained because 
of their anatomical position in the head and neck region and their relatively high 
sensitivity to ionizing radiation. Although they are not the primary indication for a CBCT 
examination, these regions are most likely irradiated during CBCT exposures as they 
are situated very close to the primary X-ray beam. As a result, they may receive 
inadvertent exposure, because of their position. The gonads area may be affected by 
scatter radiations. This region is very radiosensitive, as it harbors the reproductive cells.  
The Sirona Galileos Comfort® CBCT scanner is housed in the Wits dental hospital. 
The software installed in it is a GALAXIS, RECO® software which extends SIDEXIS to 
include the processing of 3D data. Its functions are 3D reconstructions, storage, recall, 
display and processing of 3D data. 
The tube voltage is fixed at 85kV, with a current varying between 5-7mA.There are six 
exposure settings where the tube voltage remains constant at 85kv, while the current 
may vary between 10-42mA according to the size of the patient. The different exposure 
settings available include 10, 14, 21, 28, 35 and 42mAs. 
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The Galileos Comfort® has two FOVs. The full FOV measures 15x15x15 spherically, 
and the medium FOV (upper or lower jaw only) is 8.5 x15 x 15. 
It is equipped with four viewing settings: VO1, VO1HC, VO2 and VO2HC. The 
difference between these settings is simply the resolution and the contrast. In other 
words, it is a question of image quality.  
In this study two different protocols will be used. One using the VO1 setting and the 
other using the VO2 setting. VO1 displays a high resolution and therefore has a smaller 
pixel size. As a consequence, it occupies more space in the memory and requires a 
bigger data volume (740MB). 
VO2 displays a standard resolution and therefore has a bigger pixel size. As a result, 
the data volume is smaller (approximately 390 MB).29  
These viewing settings do not influence the amount of exposure received by the patient. 
Yet, our study will compare the different amount of exposure received in the two 
different scan protocols. 
 The dosimeters exist in several types. Newly optically stimulated luminescent 
dosimeters (OSL) are the latest model in the market, but this study will make use of 
thermoluminescent dosimeters (TLDs), which are the most popular. (Fig. 2) TLDs rely 
on the principle of thermoluminescence. Their role is to measure the absorbed dose of 
radiation in the specific area, where they are placed.                                                  
Previous studies have elaborated on the reliability of lithium- fluoride TLDs. The 
superiority of lithium fluoride (LiF) over other thermoluminescent materials has been 
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established. These discs when subjected to a standardized method of annealing and 
selection may be relied upon to an accuracy of 90%. 25                                                                                                      
However, with the introduction of personal dose equivalent Hp (0.07) by the ICRP in 
1991, TLDs for external surfaces such as the skin and the lens of the eye require a 
specific calibration.16, 24The dosimeters utilized, for the purpose of this research are 
thermoluminescent TLDs (TLD100) discs.  
The Medical-physics laboratory supplied the author with the facilities for annealing, 
handling and reading of the dosimeters. The venue was equipped with a PTW-Frieburg 
1321® oven. The reader was a Harshaw 825®, model 3500. Both equipments were 
operated from a computer installed with the application softwares WINREMS for the 
reader, and THELDO for the oven. (Fig. 3, 4, 5) 
The dosimeters were handled with a Dymax 30 Charles Austen vacuum pump, in order 
to prevent their contamination. (Fig. 6) 
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2.2 Materials and methods 
The experiment took place in two different venues. The calibration and manipulation of 
the dosimeters were performed in the laboratory whilst the RANDO® phantom, although 
mounted and dismantled in the laboratory, was submitted to the exposures in the 
hospital. 
 Inclusion and exclusion criteria 
These criteria are based on the methods of selection of TLDs as discussed by Buch and 
Keddy, 1987.25 The calibration of the 67 TLDs was performed using a photon energy of 
6 MV on a Siemens linear accelerator. 1Gy of radiation was given to the batch of TLDs 
for a field size of 14cm x14cm at the depth of 4.4cm in Perspex, which is equivalent to 
5cm in water and the procedure was carried out in a black plastic container. The 49 
TLDs that did not vary more than 5% from the mean value were considered in the 
inclusion criteria. All the others were excluded. The gender of the phantom was of no 
consequence as male and female gonads are situated in the pelvic region. 
All of the 67 dosimeters responded positively to the selection criteria, in other words 
they were all below 5% of the mean absorbed dose. According to the medical physicist 
who performed the calibration, this could be justified by the fact that these dosimeters 
were still relatively new and had not been submitted to a great number of exposures. 
 The forty-nine TLDs that had the readings nearest to the mean value were therefore 
selected. 
27 
 
The first reading of the forty-nine dosimeters was done in order to measure the 
background radiation. Afterwards, the TLDs were submitted to a second annealing in 
order to exclude background radiation, prior to their insertion in the RANDO® phantom. 
For this process the chips were placed inside a square annealing copper plate provided 
with apertures to contain each dosimeter. The placement of the TLDs in the phantom 
was realized according to anatomical positions used in literature with three in each of 
the selected organs31, 32 
 For the thyroid, the TLDs were placed in position 9 of RANDO® phantom. 
For the lens of the left and the right eye, they were placed in specific pouches, held in 
place with tape on the anterior surface of the eye. As for the lower abdomen, the TLDs 
were placed on position 33 of the RANDO® phantom.                                                               
In the three organs, considering the phantom in an anatomic position, the TLDs were 
placed according to a linear pattern with one anterior, one medial and one posterior.  
All the manipulations of the dosimeters were done in the medical physics laboratory, 
where all the conditions for handling and reading of TLDs were met. 
 Once the TLDs in place, the phantom was conveyed from the medical-physics 
laboratory to the dental hospital, where the Galileos Comfort® CBCT is housed.  
In the hospital, the phantom was positioned in the machine with the midsagittal plane 
centered in the image field and the occlusal plane parallel to the scan rotation 
plane.10,14, 20, 26It was then subjected to the same type of x-ray examinations as those 
that are usually conducted on patients. (Fig.7)   
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Two different CBCT scan protocols were used for this exposure. The first one was at 
85kV, 42 mA on setting high resolution setting, and the second one at 85 kV, 42 mA on 
standard setting. 
After exposure, the phantom was returned to the medical physics laboratory, for 
reasons of appropriate manipulation and reading of TLDs. 
This procedure was repeated five times, three for the first protocol, and twice for the 
second protocol. 
Once the readings were processed, the background radiation was subtracted from the 
radiation absorbed dose for each TLD. The mean absorbed dose per organ was then 
calculated for both protocols and this led to the calculations of the different effective 
doses per organ, for both protocols, according to the ICRP specifications. 
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2.3 Results 
The data was collected in the form of tables where each selected TLD was attributed a 
specific name symbolized from 1A1 to 9G9.These calibrated TLDs kept the same 
position in the annealing copper plate during the entire experiment. The first table 
symbolizes the readings of the background radiation on each TLD. (Table 7) 
The absorbed dose of each TLD was recorded for both protocols. These doses are  
presented in tables 8, 9, 10, 11 and 12. 
The shortcomings were encountered with the calculation of the effective dose on the 
implementation of the equation: E= WT x HT x ƒ     (2)                                                             
The equivalent dose (HT) could easily be calculated as the product of the absorbed 
dose and the radiation weighting factor, based on the collected data. Limitations, 
however, were encountered with the identification of the two other parameters in the 
equation. Each organ had its own specifications for the tissue weighting factor and the 
fraction of irradiated tissue.                                                                                                             
The tissue weighting factor (WT) for the selected organs was obtained from the 
literature. However, according the ICRP 2007 publication, the eye was not viewed as an 
organ that would develop stochastic effects of ionizing radiation. It was therefore not 
listed in the ICRP 2007 guidelines, among the organs that were attributed a tissue 
weighting factor. (Table 1) However the threshold dose for cataract, considered a 
deterministic effect of ionizing radiation on the lens of the eye was clearly stipulated. A 
minimum exposure of 0.5 Sv, could induce radiation cataract. As a result, the calculated 
dose of radiation for the lens of the eye was reduced to an equivalent dose with no 
carcinogenic potential. The equivalent dose is always expressed in Sieverts. 
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 The gonads and the thyroid are attributed tissue weighting factors by the ICRP. These 
two organs are therefore considered by the ICRP, as having a carcinogenic potential 
when exposed to a minimum dose of ionizing radiation. The dose of radiation to be 
calculated for these two organs was therefore to remain an effective dose.                                                                                                                       
The determination of their respective fractions of irradiated tissues (ƒ) was a 
challenge. There are estimations for this parameter in the literature for the thyroid gland 
and other organs in the maxillo-facial region. Most of the dosimetry studies on dental 
CBCT focus on the head and neck region. As a result, this study referred to Ludlow and 
Ivanovic 2008 estimations of fraction of irradiated tissue values for the thyroid gland. 
(Table 2) The gonads were given an estimated value of 1%. This was based on the 
anatomical situation of the gonads, which are very far from the primary x-ray beam. An 
estimation of 0% would have brought our results to null.  This would have been contrary 
to the observations on the data collection which recorded an absorbed dose on the 
TLDs placed in this organ. 
Table 2: Extract of values of fraction of irradiated organs from Ludlow and Ivanovic    
Organ Fraction irradiated 
Thyroid 100% 
Eyes 100% 
Salivary glands 100% 
Skin 5% 
Mandible 1.3% 
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The values of the equivalent and effective doses calculated for each organ are 
presented in tables 3, 4and 5. The first two tables refer to the two different scan 
protocols. (Table 3-4)                                                                                                                       
The third table summarizes the average dose values after the five exposures. (Table 5) 
The average dose of exposure received on both eyes L and R is therefore: 58.995 µSv.     
The comparison of the values of the effective doses on the two resolution settings is 
illustrated on fig.1. 
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Table 3:  Effective dose of radiation per selected organ in CBCT setting VO1, 85kV, 42mA  
Selected Organ Mean Absorbed Dose 
of Radiation  (µGy( 
Tissue Weighting 
Factor      ( ICRP 2007)/ 
Radiation weighting 
factor 
Estimated Fraction of 
irradiated  tissue in % 
Dose of  Radiation 
(ICRP 2007) µSv 
L eye 35.717 1 100 35.717   HT 
R eye 68.569 1 100 68.569    HT 
Thyroid 1001.755 0.04 100 40.072     E 
Gonads 89.310 0.08 1 0.071       E 
  
Table 4:  Effective dose of radiation per selected organ in CBCT setting VO2, 85kV, 42m 
Selected Organ  
  
 
Mean Absorbed Dose 
of Radiation        µGy
  
Tissue Weighting 
Factor (ICRP 2007)/ 
Radiation weighting 
factor 
Estimated Fraction of 
irradiated tissue in % 
 Dose of 
Radiation(ICRP 
2007) µSv 
L eye 30.378 1 100 30.378 HT 
R eye 101.335 1 100 101.335  HT 
Thyroid 173.46 0.04 100 6.938    E 
Gonads 28.310 0.08 1 0.003     E 
. 
Table 5  : effective dose of radiation after the five exposures 
Selected organ Mean absorbed dose 
of Radiation µGy 
Tissue Weighting 
Factor (ICRP 
2007)/Radiation 
weighting Factor 
Fraction of irradiated 
tissue in % 
Dose of Radiation 
(ICRP  2007) µSv 
L  eye 33.04  100 33.04      HT 
R eye 84.95  100 84.95       HT 
Thyroid 587.60 0.04 100 23.500      E 
Gonads 58,81 0.08 1 0.047       E 
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Fig1: Column chart comparing values of doses of radiation on VO1 and VO2 
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CHAPTER III: CONCLUSION 
 
3.1 Discussion 
This study examined doses of ionizing radiation emitted during a CBCT examination to 
the eye, the thyroid and the gonads. Of all the organs exposed, the eye was the one 
which seemed to show the highest dose of radiation. This could easily be explained by 
the fact that the dose of exposure to the eye is an equivalent dose that is not influenced 
by tissue weighting factors. One must therefore not compare the doses calculated for 
the eye with those for the two other organs which may develop stochastic effects, 
according to the ICRP 2007. The average equivalent dose for the lens of the eye was 
59µSv. A dose of this nature, being almost 10 000 times less than the threshold, may be 
considered negligible for producing a cataract. Literature has reported an estimated 
dose of background radiation per annum received by every individual in normal 
circumstances of approximately of 3mSv. However, there is a great discrepancy 
between the equivalent dose of 0.059mSv to the eye as calculated in this study and the 
absorbed dose of 0.94mGy calculated by Akyalcin et al. in 2013. Such a comparison 
seems possible because the radiation weighting factor in the equation for calculating the 
equivalent dose, based on absorbed dose, is 1. As a result, the dose calculated by  
Akyalcin et al. seems to be 20 times greater. One must bear in mind that although both 
these studies used the Sirona Galileos Comfort® CBCT scanner with similar scan 
protocols and FOVs, as well as the organ dose measurement methodology, the 
equipments used and the methods of calibration of dosimeters were totally different. 
One study used the standard method of calibration used for deep tissues, while the 
other used specific calibration of dosimeters and coefficients relative to external 
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surfaces. Another factor that could explain the discrepancy is the different types of 
dosimeters used in both studies i.e. LiF versus OSL dosimeters. Nevertheless, both 
results were relatively low.  
The gonads showed results approximating the null figure attributed to the study effected 
by Chambers D, 2014. The effective dose of 0.05µSv could be considered negligible. 
This is consistent with Alkyacin et al.’s theory that justified the low dosage obtained at 
the skin surface of the thyroid by considering it as being situated in the scatter region. 
The thyroid was the organ where calculation of effective dose was the least challenging 
as all the parameters to determine the effective dose were present. The specific 
calibration of the dosimeters was that indicated for deep tissues. The organ is 
anatomically situated in the proximity of the primary beam. However, Ludwig and 
Ivanovic do not consider it as part of the scatter as they attributed it a fraction of 
irradiated tissue similar to that of the salivary glands, which, anatomically are definitely 
situated inside the primary beam. The figure of 23.5 µSv recorded in this study as an 
effective dose for the thyroid is difficult to compare with doses in the literature because 
most of the doses for this specific organ found in the literature are equivalent or 
absorbed doses, the radiation weighting factor for X-rays being 1. However, the ICRP 
classifies the thyroid as an organ that could develop cancer or mutation related to 
ionizing radiation. As a result, the calculation of radiation exposure on this organ must 
take into consideration the tissue weighting factor and the fraction of irradiated tissue. 
This justifies the use of effective dose for the thyroid gland in this study.  
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 These different types of dosages of the amount of radiation for one specific organ set a 
limitation to our comparison between the doses in the study and the ones in literature. 
Yet, the average full body doses recorded in literature are effective doses. They are 
therefore comparable to the doses in the current study. Ludlow and Ivanovic calculated 
128µSv for full FOV and maximum exposure, whereas Chambers recorded an exposure 
of 140µSv for similar conditions. The manufacturer’s effective dose for a similar protocol 
was shown to be the same as that of Ludlow and Ivanovic i.e. 128µSv. 
 Considering the author’s recording of 24µSv for the thyroid, one could estimate it as 
approximately 19% of the full body average effective dose as compared to Ludlow and 
17% compared to Chambers. In other words, the thyroid, according to the study under 
consideration, would be absorbing approximately 20% of the full body irradiation 
emanating from a CBCT scan.  
It has been established that the amount of radiation to which a patient is exposed during 
a CBCT examination is a function of the FOV, the kV of the machine and the amperage 
setting. One of the objectives of this study was to compare the readings on the high 
resolution and standard settings of the Galileos Comfort® CBCT without changing the 
FOV, the kV or the mA. Chambers compared the two settings on the same machine 
with a similar scan protocol and concluded that the there was no significant difference in 
the effective doses. The study under consideration compared the two resolution settings 
at an organ level. There was found to be a discrepancy between the two scan protocols 
in general, although the greatest discrepancies were found for the right eye and the 
thyroid. LiF dosimeters have been used in several organ dose measurement studies, 
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and their reliability has been shown in previous studies. Also the phantom used is 
appropriate for the type of dosimeters used. It has, in fact, been established that the 
majority of cases recorded in the literature were done on an anthropomorphic phantom 
and LiF TLDs.21 
According to literature studies, discrepancies have been explained by the position of 
dosimeters in the apertures of the phantom.26Indeed, in the three organs studied, the 
dosimeters were placed in sets of three, in a linear pattern: one anterior, one medial and 
one posterior. This means that one dosimeter was always cranial to the field of radiation 
while another was always caudal to the field. This fact might explain the discrepancies 
on all three organs. 
Another observation is that the method of calibration of dosimeters used in this study for 
both the eyes and the other organs was similar. Literature studies consider the eye to 
be a superficial structure and therefore require the calculation of a personal dose 
equivalent for this organ. 
Finally, the discrepancy might be the result of the number of exposures for each setting. 
Indeed, three exposures were carried out for the high resolution, while the standard 
resolution was only submitted to two exposures. The different population samples 
considered in the calculation of the means for both scan protocols could have 
influenced the results.  
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3.2 Conclusion 
 
CBCT is a very useful tool in dentistry. However our study has demonstrated low doses 
of radiation to the eye, a fairly insignificant amount of scatter to the gonads and a 
contribution of approximately 20% of the full body dose to the thyroid. For a child of 
about 12 years undergoing orthodontic treatment this could be considered a fairly 
substantial dose. However, compared to our measurement of background radiation 
these doses are still relatively low. As for the different resolution settings, further studies 
at an organ level are still needed in order to justify these values. Meanwhile application 
of the ALARA (As Low As Reasonably Achievable) principle by reduction of the FOV 
and mA settings where applicable as well as a specific indication for a CBCT 
examination is essential.    
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Appendices 
Appendix 1: 
Table 6: Dose values for different exposure settings in full FOV29  Deff: effective dose value -      
Programs 1 2 3 4 5 6 
Values 10 mAs 14mAs 21 mAs 28mAs 35mAs 42mAs 
Deff ICRP 1991 14µSv 19 µSv 28 µSv 39 µSv 48 µSv 52 µSv 
Deff ICRP 2007 30µSv 41 µSv 70 µSv 83 µSv 103 µSv 128µSv 
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Appendix 2 :Table 7: name of dosimeter and value of background radiation associated  
1A1 
72.9 
1B1 
10.92 
1C1 
6.139 
1D1 
7.332 
1E1 
11.24 
1F1 
3.865 
1G1 
Skipped 
2A2 
30.53 
2B2 
7.378 
2C2 
4.415 
2D2 
3.765 
2E2 
3.229 
2F2 
Skipped 
2G2 
3.271 
3A3 
21.16 
3B3 
11.59 
3C3 
8.167 
3D3 
4.034 
3E3 
2.698 
3F3 
6.036 
3G3 
4.222 
4A4 
5.846 
4B4 
5.128 
4C4 
3.840 
4D4 
3.929 
4E4 
2.281 
4F4 
2.562 
4G4 
5A5 
48.77 
5B5 
2.75 
5C5 
6.001 
5D5 
7.345 
5E5 
2.412 
5F5 
2.706 
5G5 
6A6 
Rejected 
6B6 
Rejected 
6C6 
Flagged as 
bad 
6D6 
Rejected 
6E6 
3.192 
6F6 
3.105 
6G6 
7A7 
13.47 
7B7 
3.339 
7C7 
2.411 
7D7 
8.966 
7E7 
2.645 
7F7 
3.215 
7G7 
8A8 
7.202 
8B8 
3.778 
8C8 
2.892 
8D8 
Skipped 
8E8 
8.404 
8F8 
2.734 
8G8 
9A9 
6.197 
9B9 
4.326 
9C9 
2.545 
9D9 
4.355 
9E9 
3.420 
9F9 
Skipped 
9G9 
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Appendix 3 
Scan protocol 1 
Table 8: First measurement of absorbed doses on the three selected organs after exposure with the Galileos Comfort CBCT on 
setting VO1, 85kV, 42mA                                                                                                              
TLD name and selected 
organ p 
Absorbed  dose of 
radiation Reading (µGy) 
Background Radiation    ( 
µGy) 
Absorbed dose of 
radiation on Organ (µGy) 
 
1A1     Gonads 114,4 72,9 41,5 
2A2     Gonads 78,54 30,53 48,01 
3A3     Gonads 48,57 21,16 27,41 
4A4     R eye 31,01 5,84 25,17 
5A5     R eye 50,34 48,77 1,57 
6A6     Rejected _ Rejected _ 
7A7     R eye 36,63 13,47 23,16 
8A8     L eye 35,52 7,202 28,318 
9A9     L eye 38,55 6,197 32,353 
1B1     L eye 38,79 10,92 27,87 
2B2     Thyroid 796,1 7,378 788,722 
3B3     Thyroid 962,9 11,59 951,31 
4B4      Thyroid 2332 5,128 2326,872 
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 Appendix 4 
Table 9: Second measurement of the absorbed dose on the three selected organs, after exposure with Galileos Comfort CBCT 
on setting VO1, 85 kV and 42 mA 
TLD name and  selected 
organ  
Absorbed dose of radiation 
reading  (µGy) 
Background Radiation (µGy)
  
Absorbed dose of radiation 
on Organ (µGy) 
 
1A1     R eye 181.4 72.9 108.5 
2A2     R eye 103.4 30.53 72.87 
3A3     R eye 75.48 21.16 54.32 
4A4     L eye 50.67 5.846 44.824 
5A5     L eye 37.04 48.77 Incoherent 
6A6     Rejected _                _          _ 
7A7     L eye 35.77 13.47 22.3 
8A8     Thyroid 276.4 7.202 269.198 
9A9     Thyroid 208.3 6.197 202.103 
1B1     Thyroid 264.7 10.92 253.78 
2B2     Gonads 301.6 7.378 294.222 
3B3     Gonads 44.7 11.59 33.11 
4B4     Gonads Rejected  5.128                       _ 
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Appendix 5 
Table 10: Third measurement of absorbed dose on the three selected organs, after exposure with Galileos Comfort CBCT on 
setting VO1, 85 kV and 42 mA 
TLD name and  selected 
organ    
  
Absorbed dose of radiation 
reading  (µGy) 
Background  Radiation 
(µGy)  
Absorbed dose of radiation 
on Organ (µGy) 
 
5B5     Gonads 40.22 2.75 37.47 
7B7     Gonads 100.6 3.339 97.261 
8B8     Gonads 64.93 3.778 61.152 
9B9     Thyroid 100.7 4.326 96.374 
1C1     Thyroid 2667 6.139 2660.861 
2C2     Thyroid 1471 4.415 1466.585 
3C3     R eye 224.8 8.167 216.633 
4C4     R eye 115.1 3.840 111.26 
5C5     R eye 63.96 6.001 57.959 
6C6          _            _ Flagged as bad  
7C7     L eye 47.58 2.411 45.169 
8C8     L eye 46.73 2.892 43.838 
9C9     L eye 45.77 2.545 43.225 
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Appendix 6 
Scan protocol 2 
Table 11: First measurement of absorbed dose of radiation per selected organs, after exposure with Galileos Comfort CBCT on 
setting VO2, 85 kV and 42 mA 
TLD name and  selected 
organ 
Absorbed dose of radiation 
reading  (µGy 
 Background Radiation (µGy)
  
Absorbed dose of radiation 
on Organ (µGy) 
1D1     Gonads 31.58 7.332 24.248 
2D2     Gonads 21.20 3.765 17.435 
3D3     Gonads 21.36 4.034 17.02 
4D4     Thyroid 37.95 3.929 34.021 
5D5     Thyroid 273.5 7.345 266.155 
6D6         _ Rejected       _ 
7D7     Thyroid 221.7 8.966 212.734 
8D8        _ Skipped       _ 
9D9     R eye 46.75 4.355 42.395 
1E1      R eye 61.56 11.24 50.32 
2E2      R eye 29.53 3.229 26.301 
3E3     L eye 35.64 2.698 32.942 
4E4     L eye 29.90 2.281 27.619 
5E5     L eye 30.27 2.412 27.858 
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Appendix 7 
Table 12: Second measurement of absorbed dose of radiation per selected organ, after exposure with Galileos Comfort CBCT on 
setting VO2, 85 kV and 42 mA 
TLD name and  selected 
organ   
   
 
Absorbed dose of radiation 
reading  (µGy 
Background Radiation (µGy) Absorbed dose of radiation 
per Organ (µGy) 
6E6     Gonads 40.89 3.192 37.698 
7E7     Gonads 38.41 2.645 35.765 
8E8     Gonads 29.53 8.404 21.126 
9E9     Thyroid 300.9 3.420 297.48 
1F1     Thyroid 123.4 3.865 119.535 
2F2             _ Skipped          _ 
3F3     Thyroid 116.9 6.036 110.864 
4F4     R eye 367.8 2.562 365.238 
5F5     R eye 80.32 2.706 77.614 
6F6     R eye 49.25 3.105 46.145 
7F7     L eye 49.44 3.215 46.225 
8F8     L eye 22.85 2.734 20.116 
9F9       _ Skipped         _ 
1G1       _ Skipped          _ 
2G2     L eye 30.79 3.271 27.519 
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Appendix 8 
Tables 13,14 and 15 
Table 13: Mean absorbed dose of radiation per selected organ in CBCT setting VO1, 85 kV, 42mA 
Selected  Organ  Average  exposed 
dose on first 
exposure (µGy) 
Average exposed 
dose on second 
exposure (µGy) 
Average exposed 
dose on third 
exposure (µGy) 
Mean dose of 
exposure (µGy) 
L eye 29.514 33.56 44.077 35.717 
R eye 16.633 60.458 128.617 68.569 
Thyroid 1355.634 241.693 1407.94 1001.755 
Gonads 38.973 163.666 65.29 89.310 
 
Table 14:  Mean absorbed dose of radiation per selected organ in CBCT setting VO2, 85 kV, 42 mA 
Selected  Organ    
 
 
Average  exposed dose on 
first exposure (µGy) 
Average exposed dose on 
second exposure (µGy)
  
Mean dose of exposure 
(µGy) 
L eye 29.47 31.287 30.378 
R eye 39.672 162.999 101.335 
Thyroid 170.97 175.95 173.46 
Gonads 19.567 37.054 28.310 
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Table 15: Comparison of effective doses of radiation on selected  
Selected  Organ    Dose of radiation in setting VO1 (µSv) Dose of radiation in setting VO2 (µSv) 
L eye 35.717   HT 30.378       HT 
R eye 68.569    HT 101.335       HT 
Thyroid 40.072     E 173.46          E 
Gonads 0.071       E 28.310          E 
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Appendix 9 
Figures 2, 3, 4, 5 
 
 
                                                                                                 
Fig 2: Copper plate with LIF TLDs                             Fig 3: Computer with softwares 
                     
Fig 4:  Annealing oven: PTW Frieburg 1321®          Fig 5: Hasrhaw  3500 ®reader 
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Appendix 10 
Figures 6 and 7 
                 
Fig 6:   Vacuum pump                                                   Fig 7:  Rando® positioned inside the 
CBCT                     
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